NCT02334358已完成不适用
A Multi-center, Prospective and Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s Injected Into the Nasolabial Folds
LG Life Sciences1 个研究点 分布在 1 个国家目标入组 503 人开始时间: 2014年9月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 503
- 试验地点
- 1
- 主要终点
- Incidence of Device-related Adverse Events
研究概览
简要总结
To evaluate long-term safety of YVOIRE classic s by incidence of adverse events including injection site local reactions and biodegradability
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subjects whose age is over 18 years old
- •Subjects whose WSRS grade is equal or greater than 2
- •Subjects must be willing and able to provide written informed consent
- •Subjects who are scheduled to be treated with YVOIRE classic s for facial tissue augmentation to correct the nasolabial folds
排除标准
- •Subjects who are sensitive to hyaluronic acid or any excipients of YVOIRE classic s
- •Subjects who have received permanent implantation (silicone, PAAG, PMMA, CaHA etc) on the nasolabial folds
- •Subjects who have received nonpermanent aesthetic treatments, such as botulinum toxin injection or filler on the nasolabial folds within 9 months before screening
- •Subjects who have received face lifting or plastic surgery on face within 9 months before screening
- •Subjects who have received laser therapy on the nasolabial folds, chemical peeling or peeling on face within 3 months before the screening
- •Subjects who have any skin diseases (including inflammation and skin cancer) or infectious diseases on the injection sites
- •Subjects who tend to have hypertrophic scars
- •Subjects with a history of streptococcal disease, severe allergy or anaphylaxis or bleeding disorders.
- •Women in pregnancy or lactation
结局指标
主要结局
Incidence of Device-related Adverse Events
时间窗: Until subject reaching total biodegradation criterion (WSRS change) ; an expected average of 2 years.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume sCorrection of Nasolabial FoldsNCT02661737LG Life Sciences503
已完成
不适用
Extension Clinical Study to Evaluate the Long-term Efficacy and Safety of Repeat Treatment of YVOIRE Contour Injected Into the Anteromedial Malar Region in Subjects Who Have Completed the LG-HACL014 StudyNormal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region Who Have Completed the LG-HACL014 StudyNCT02119793LG Life Sciences13
已完成
2 期
Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent PatientsHemochromatosisNCT00349453Lipomed24
已完成
不适用
To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face VolumeMidface Volume DeficitNCT04784299LG Chem105
招募中
不适用
Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term UseMigraine DisordersNCT05342493Otsuka Pharmaceutical Co., Ltd.1,000